OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X.
Dai W, et al. Among authors: liu h, liu t.
J Hepatol. 2020 May;72(5):909-923. doi: 10.1016/j.jhep.2019.12.015. Epub 2019 Dec 30.
J Hepatol. 2020.
PMID: 31899205